Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




监测血糖的生物传感器系统

By LabMedica International staff writers
Posted on 02 Feb 2018
目前,无创监测葡萄糖测量值、准确性不稳定,与血糖关联度弱,且不能检测睡眠时的高血糖/低血糖,所以还未广为人知。

对糖尿病患者进行受控的连续葡萄糖监测(CGM)能更好地监测和控制血糖水平,并预防并发症,而市售的产品监测葡萄糖需要用创伤性的针刺手段。

清华大学的科学家研制了一款皮肤样的生物传感器系统,用于无创原位静脉内血糖监测。该系统集成了一只超薄皮肤样生物传感器与纸电池供电的电化学双通道(ETC)。特制的皮下ETC把血糖压出血管,运送到皮肤表面。

超薄(约3微米)纳米结构生物传感器灵敏度高(130.4 μA/mM),顺应性极强,能完全吸收和测量葡萄糖。这种超薄皮肤样生物传感器能完全贴合皮肤,测量受ETC驱动向外运动的葡萄糖。这些生物传感器是多层的“沙丘”状纳米结构,表现出更好的电化学特性和更高的灵敏度。

科研小组进行了人体临床实验。用市售的罗氏公司的ACCU-CHEK Performa血糖计和静脉留置针做创伤性的葡萄糖测量。用无创的皮肤样血糖监测系统测量静脉内血糖和组织间液(ISF)里的血糖。ETC极大提高了无创测量结果与真实血糖水平之间的关联。该系统经过正确校准后有望适用于医用级CGM,与微型胰岛素泵配套使用时可实施胰岛素疗法。该研究的论文发表于2017年12月1日的《科学进展》(Science Advances)杂志。

Related Links:
清华大学
罗氏公司 


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.